[ Anaconda BioMed raises $16.83M in Series A ]
Anaconda BioMed has raised $16.83 million in Series A funding.
Founded in 2015, Anaconda BioMed is a a pre-clinical stage medical device company focused on the development of the next generation of neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS).
The company intends to use the funds to advance the development of its solution.
|Founder / CEO||Ofir Arad|
|Previous Investors||Innogest Capital|